BioXcel Therapeutics (BTAI) Operating Margin Growth (1y) (2023 - 2026)
BioXcel Therapeutics (BTAI) Operating Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.46 Mn | 24.46 Mn | 160,000.00 | 760,945.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 760,945.00 |
| Mar 31, 2026 | 104,869.00 |
| Dec 31, 2025 | -114,947.00 |
| Sep 30, 2025 | -737,211.00 |
| Jun 30, 2025 | -1.16 Mn |
| Mar 31, 2025 | -185,959.00 |
| Dec 31, 2024 | 241,896.00 |
| Sep 30, 2024 | 701,708.00 |
| Jun 30, 2024 | 990,248.00 |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.43 Mn |